Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
5,900
Employees5,900
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
5,900
Employees5,900

MEDP Key Statistics

Market cap
16.40B
Market cap16.40B
Price-Earnings ratio
41.48
Price-Earnings ratio41.48
Dividend yield
Dividend yield
Average volume
210.75K
Average volume210.75K
High today
$595.91
High today$595.91
Low today
$578.84
Low today$578.84
Open price
$589.34
Open price$589.34
Volume
215.90K
Volume215.90K
52 Week high
$628.92
52 Week high$628.92
52 Week low
$250.05
52 Week low$250.05

Stock Snapshot

The current Medpace(MEDP) stock price is $582.48, with a market capitalization of 16.4B. The stock trades at a price-to-earnings (P/E) ratio of 41.48.

On 2026-01-31, Medpace(MEDP) stock moved within a range of $578.84 to $595.91. With shares now at $582.48, the stock is trading +0.6% above its intraday low and -2.3% below the session's peak.

Trading volume for Medpace(MEDP) stock has reached 215.9K, versus its average volume of 210.75K.

The stock's 52-week range extends from a low of $250.05 to a high of $628.92.

The stock's 52-week range extends from a low of $250.05 to a high of $628.92.

MEDP News

Simply Wall St 5d
Will Earnings Upside and Aggressive Buybacks Change Medpace Holdings' Capital Allocation Narrative?

In its fourth-quarter 2025 investor letter, Vulcan Value Partners highlighted Medpace Holdings’ strong free cash flow, solid balance sheet, and management quali...

Will Earnings Upside and Aggressive Buybacks Change Medpace Holdings' Capital Allocation Narrative?

Analyst ratings

60%

of 15 ratings
Buy
6.7%
Hold
60%
Sell
33.3%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.